Make an inquiry
Refer a patient

We noticed you are on our US page. Want to switch regions? Choose from the options:

UK
AU
ES
GenesisCare - logo
Patients
Cancer care
Exploring cancer care
Breast cancer
Prostate cancer
All cancers we treat
Your care team
Treatment and services
Radiation therapy
Urology
Pulmonology
Surgery
Medical oncology
Skinviva
Cancer diagnosis
International services
Clinical trials
About clinical trials
Find a clinical trial
Patient support
Patient resources
Financial & insurance information
Common questions
Helpful organisations
Tips for caregivers
Wellbeing blog
Patient stories
Covid-19
About us
Who we are
Our leadership team
Careers
News
Contact us
Healthcare professionals
Technology
Research
Clinical trials
Publications
Collaborating together
Refer a patient
Join the network
COVID-19
Support for clinicians
Find a location
Find a doctor
GenesisCare - logo
Make an inquiry
Refer a patient

We noticed you are on our US page. Want to switch regions? Choose from the options:

UK
AU
ES
Find a location
Find a doctor
Patients
Cancer care
Exploring cancer care
Breast cancer
Prostate cancer
All cancers we treat
Your care team
Treatment and services
Radiation therapy
Urology
Pulmonology
Surgery
Medical oncology
Skinviva
Cancer diagnosis
International services
Clinical trials
About clinical trials
Find a clinical trial
Patient support
Patient resources
Financial & insurance information
Common questions
Helpful organisations
Tips for caregivers
Wellbeing blog
Patient stories
Covid-19
About us
Who we are
Our leadership team
Careers
News
Contact us
Healthcare professionals
Technology
Research
Clinical trials
Publications
Collaborating together
Refer a patient
Join the network
COVID-19
Support for clinicians
Make an inquiry
Refer a patient
  • Healthcare Professionals
  • Latest research
  • Publications
  • Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial.
20 Oct 2021

Darolutamide and health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: An analysis of the phase III ARAMIS trial

written by
Sylvester John E, MD
Matthew R.Smith, Neal Shore, Teuvo L.Tammelac Albertas Ulys, Egils Vjaters, Sergey Polyakov, Mindaugas Jievaltas, Murilo Luz, Boris Alekseev, Iris Kuss, Marie-Aude Le Berre, Ateesha F.Mohamed, Dawn Odom, Jennifer Bartsch, Amir Snapir, Toni Sarapohja, Karim Fizazi Journal: European Journal of Cancer , volume: Volume 154 , pages 138-146
US Genesis Logo

GenesisCare

About us
COVID-19

Website policies

Website terms of use
HIPAA notice of privacy practices
Su información. Sus derechos. Nuestras responsabilidades
Notice of non-discrimination
Aviso de No Discriminación
Financial conflict of interest in research
Language assistance services
Privacy policy
Do not sell my personal information
Cookie Preferences

Contact us

Make an inquiry
Request medical records

Media & Social

News Room - What's been happening
Facebook
Twitter
LinkedIn
Youtube
Vimeo
Facebook

Copyright © 2022 GenesisCare. All Rights Reserved.